HEALTH CARE SECTOR

BIOTECHNOLOGY INDUSTRY

Last $3.99 USD

Change Today -0.09 / -2.21%

Volume 2.4M

DNDN On Other Exchanges

Symbol

Exchange

NASDAQ GS

Frankfurt

As of 8:10 PM 06/19/13 All times are local (Market data is delayed by at least 15 minutes).

Name (Connections)	Board Relationships	Title	Key Developments
Douglas Watson	68 Relationships	Lead Independent Director and Chairman of Audit Committee	Securities and Exchange Commission Launches Informal Probe into Dendreon Corp 07/11/07
Pedro Granadillo B.S.	60 Relationships	Director, Chairman of Compensation Committee and Member of Audit Committee
Dennis Fenton Ph.D.	220 Relationships	Director, Member of Audit Committee and Member of Corporate Governance Committee

Name (Connections)	Board Relationships	Title
Susan Bayh J.D.	40 Relationships	Director, Member of Corporate Governance Committee and Member of Compensation Committee
Bogdan Dziurzynski Ph.D., MBA, D.P.A.	34 Relationships	Director, Chairman of Corporate Governance Committee and Member of Compensation Committee
Pedro Granadillo B.S.	60 Relationships	Director, Chairman of Compensation Committee and Member of Audit Committee

DNDN Compensation vs. Industry
736.4K 374.5K Chief Executive Officer
437.0K 267.2K Chief Financial Officer
52 Week Price Performance

DNDN

Industry Average

Name (Connections)	Board Relationships	Title
Susan Bayh J.D.	40 Relationships	Director, Member of Corporate Governance Committee and Member of Compensation Committee
Bogdan Dziurzynski Ph.D., MBA, D.P.A.	34 Relationships	Director, Chairman of Corporate Governance Committee and Member of Compensation Committee
Dennis Fenton Ph.D.	220 Relationships	Director, Chairman of Compensation Committee and Member of Audit Committee
David Stump M.D.	16 Relationships	--

DNDN and Competitor Insiders vs. External Board
25% 75% Dendreon Corp.
14% 86% Vical Incorporated
14% 86% Sarepta Therapeutics, Inc.
11% 89% Spectrum Pharmaceuticals, Inc.
18% 82% Progenics Pharmaceuticals, Inc.
21% 79% Amarin Corporation plc

Insiders

External Board Members

*Data is at least as current as the most recent Definitive Proxy.

Market data is delayed at least 15 minutes.

Recently Viewed
DNDN:US	$3.99 USD	-0.09

Market data is delayed at least 15 minutes.

Company	Last	Change
Amarin Corp PLC	$6.47 USD	-0.13
Progenics Pharmaceuticals Inc	$4.80 USD	-0.01
Sarepta Therapeutics Inc	$39.78 USD	+1.63
Spectrum Pharmaceuticals Inc	$8.17 USD	-0.11
Vical Inc	$3.11 USD	+0.03
View Industry Companies

DNDN

Industry Average